Pathophysiology of Type 2 Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 293 of the 297 references it cites were found in a registry or an index.
Abstract
Type 2 Diabetes Mellitus (T2DM), one of the most common metabolic disorders, is caused by a combination of two primary factors: defective insulin secretion by pancreatic β-cells and the inability of insulin-sensitive tissues to respond appropriately to insulin. Because insulin release and activity are essential processes for glucose homeostasis, the molecular mechanisms involved in the synthesis and release of insulin, as well as in its detection are tightly regulated. Defects in any of the mechanisms involved in these processes can lead to a metabolic imbalance responsible for the development of the disease. This review analyzes the key aspects of T2DM, as well as the molecular mechanisms and pathways implicated in insulin metabolism leading to T2DM and insulin resistance. For that purpose, we summarize the data gathered up until now, focusing especially on insulin synthesis, insulin release, insulin sensing and on the downstream effects on individual insulin-sensitive organs. The review also covers the pathological conditions perpetuating T2DM such as nutritional factors, physical activity, gut dysbiosis and metabolic memory. Additionally, because T2DM is associated with accelerated atherosclerosis development, we review here some of the molecular mechanisms that link T2DM and insulin resistance (IR) as well as cardiovascular risk as one of the most important complications in T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“T2D is considered a polygenic condition with considerable heterogeneity in degrees of insulin deficiency and resistance and accounts for >90% of all cases of DM.32”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“Likewise, diabetes is secondary to altered glucose homeostasis [67], and this study suggests a critical role for NHE3 in the regulation of SGLT1, which is the predominant intestinal glucose transporter.”
From Regulation of Enterocyte Brush Border Membrane Primary Na-Absorptive Transporters in Human Intestinal Organoid-Derived Monolayers (2024) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 2×
“A critical component of T2DM is a chronic low-grade inflammatory state, referred to as “metaflammation” [250].”
Background10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“Among them, the UKPDS post-trial study and Steno-2 trial showed that specifically early glycemic interventions prevent diabetic complication and has a marked decrease in CVD endpoints in patients that received either standard or intensive treatment following their diagnosis [84].”
BackgroundHaffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931 · cited 1×
“In these circumstances, as a consequence of nutrient overload, electron supply to the mitochondrial ETC increases and the electron excess is transferred to oxygen generating O2− and subsequent hydrogen peroxide [127].”
BackgroundMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 1×
“A high-fat diet can induce up to threefold lipopolysaccharide (from Gram-negative bacteria) production in mice models, thereby contributing to low-grade inflammation and insulin resistance [76,77].”
BackgroundEckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Research works printed but not linked: 1
- Simmons D. Epigenetic Influences and Disease Nat. Educ. 2008 1 6
Cited by
Items 401–500 of 1,005
Ficus benghalensis promotes the glucose uptake- Evidence with in silico and in vitro
Madiwalar, V. S., Dwivedi, P. S. R., Patil, A. K., Gaonkar, S. M. N., Kumbhar, V. J., Khanal, P., & Patil, B. M. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-00989-2 · Cited by 21
“α-amylase and α-glucosidase [34] and the glucose transporters [35].”
BackgroundJang, H., Joung, H., Chu, J., Cho, M., Kim, Y.-W., Kim, K. H., Shin, C. H., Lee, J., & Ha, J. (2024) · Nutrients · doi:10.3390/nu16244260 · Cited by 21
Social determinants of health and type 2 diabetes in Asia
Sung, K., & Lee, S. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70024 · Cited by 29
Ayoub, S., Arabi, M., Al-Najjar, Y. A., Laswi, I., Outeiro, T. F., & Châari, A. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05051-9 · Cited by 27
“This chronic metabolic disorder is marked by insulin resistance, impaired insulin secretion, and hyperglycemia [6].”
SGLT2 inhibitors as metabolic modulators: beyond glycemic control in type 2 diabetes
Wu, Q., Zhang, J., Zhang, F., & Li, D. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1601633 · Cited by 38
The role of glucose metabolism in wound healing: an overview
Zhang, T., Yang, Y., Jiang, J., Du, W., Huang, G., Du, D., & Tao, S. (2025) · Burns & Trauma · doi:10.1093/burnst/tkaf053 · Cited by 26
Estrogen and Metabolism: Navigating Hormonal Transitions from Perimenopause to Postmenopause
Patel, P. R., Patil, S., & Kaur, N. (2025) · Journal of Mid-life Health · doi:10.4103/jmh.jmh_75_25 · Cited by 40
“[13,14] Estrogen plays a crucial regulatory role in metabolic processes during reproductive years, with significant changes during menopausal transitions.”
Olaniyi, K. S., Amusa, O. A., Ajadi, I. O., Alabi, B. Y., Agunbiade, T. B., & Ajadi, M. B. (2021) · Reproductive Toxicology · doi:10.1016/j.reprotox.2021.10.008 · Cited by 22
A novel model mouse for type 2 diabetes mellitus with early onset and persistent hyperglycemia
Ohno, T., Miyasaka, Y., Yoshida, K., Kobayashi, M., Horio, F., Yokoi, N., Mizuno, M., & Ikegami, H. (2022) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.22-0061 · Cited by 19
Wrench, E., Rattley, C. A., Lambert, J. E., Killick, R., Hayes, L. D., Lauder, R. M., & Gaffney, C. J. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01918-8 · Cited by 25
Jiang, N., & Zhang, Y. (2022) · Human & Experimental Toxicology · doi:10.1177/09603271221126487 · Cited by 25
“These abnormalities are caused by total or relative insulin secretion and/ or action.(2) Chronic hyperglycemia in diabetes is associated with prolonged damage, dysfunction, and eventually the failure of organs, particularly the eyes, cardiovascular, kidneys, and nervous system.”
BackgroundMugri, M. H. (2022) · Medicina · doi:10.3390/medicina58111605 · Cited by 24
“Diabetes mellitus is a chronic, non-communicable, metabolic disease characterized by hyperglycemia and is attributed to a combination of defective insulin secretion by β-cells of the pancreas and the inability of insulin-sensitive tissues to respond to the secreted insulin [1].”
BackgroundYang, S., Yoon, J., Lee, Y., Park, B., & Jung, D. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s389889 · Cited by 20
“First, pathophysiology of T2DM has been characterized by decreased insulin secretion by pancreatic β-cells and the inability of tissue to respond to insulin.(29) Studies have shown a high correlation of T2DM with obesity, especially visceral fat.”
BackgroundGenetic Risk Scores for the Determination of Type 2 Diabetes Mellitus (T2DM) in North India
Shitomi-Jones, L. M., Akam, E. C., Hunter, D. J., Singh, P., & Mastana, S. S. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043729 · Cited by 21
“T2DM is characterised by insulin resistance, resulting in poor blood glucose control and hyperglycaemia [5].”
BackgroundDistinct Metabolomic Profiling of Serum Samples from High-Fat-Diet-Induced Insulin-Resistant Mice
Tomar, M. S., Sharma, A., Araniti, F., Pateriya, A., Shrivastava, A., & Tamrakar, A. K. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00028 · Cited by 26
Screening marker genes of type 2 diabetes mellitus in mouse lacrimal gland by LASSO regression
Pei, X., Qi, D., Liu, J., Si, H., Huang, S., Zou, S., Lu, D., & Li, Z. (2023) · Scientific Reports · doi:10.1038/s41598-023-34072-4 · Cited by 21
Zhao, R., Li, N., Liu, W., Liu, Q., Zhang, L., Peng, X., Zhao, R., & Hu, H. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109401 · Cited by 23
Zhou, J., Shi, Y., Yang, C., Lü, S., Zhao, L., Liu, X., Zhou, D., Luo, L., & Yin, Z. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109404 · Cited by 23
Arrieta-Leandro, M. C., Moncada‐Jiménez, J., Morales-Scholz, M. G., & Hernández‐Elizondo, J. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02144-x · Cited by 26
“According to International Diabetes Federation (IDF), there are 537 million people with diabetes in the world [1] and approximately 90% of them have type 2 diabetes (T2D) [2, 3].”
BackgroundLiang, W., Feng, Y., Yang, D., Qin, J., Zhi, X., Wu, W., & Jie, Q. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00716-4 · Cited by 23
Ren, Y., Li, Z., Li, J., Liang, R., Wang, Z., Bai, Y., Yang, Y., Tang, Q., Fu, Y., Zhang, X., et al. (2023) · Obesity Reviews · doi:10.1111/obr.13639 · Cited by 27
“91 The significant decline of insulin secretion was observed in β -cells with the decreased m 6 A by METTL3 knockout.”
BackgroundHuang, H., Zhao, T., Li, J., Shen, J., Xiao, R., & Ma, W. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12754-3 · Cited by 24
Dhali, B., Chatterjee, S., Das, S. S., & Cruz, M. D. (2023) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.038.02.20 · Cited by 40
Zhou, D., Liang, Q., Ge, X., & Xu, J. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.02.020 · Cited by 29
Antidiabetic Potential of Plants from the Caribbean Basin
Méril-Mamert, V., Ponce‐Mora, A., Sylvestre, M., Lawrence, G., Bejarano, E., & Cebrián‐Torrejón, G. (2022) · Plants · doi:10.3390/plants11101360 · Cited by 20
“T2D accounts for 90 percent of incidence and usually begins in adulthood [3].”
BackgroundObesity and Exercise: New Insights and Perspectives
James, N. M., & Stanford, K. I. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf017 · Cited by 20
New Insights into Traditional Chinese Medicine in Treatment of Diabetic Nephropathy
Chung, J. Y., Lan, H.-Y., & Tang, P. M. (2023) · Integrative Medicine in Nephrology and Andrology · doi:10.1097/imna-d-22-00026 · Cited by 20
Famuyiwa, S. O., Ahmad, S., Oshiomah, K. O. O. O., Olanudun, E. A., Bano, N., Oguntimehin, S. A., Adesida, S. A., Oyelekan, E. I., Raza, K., & Faloye, K. O. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2291174 · Cited by 19
“…by insulin resistance and a lack of insulin secretion, whose rise in prevalence has been a significant global concern (Jaacks et al., 2016; Galicia-Garcia et al., 2020) Studies have shown that the global burden of diabetes is currently about 485 million people were estimated to have DM…”
Yuan, H., Xu, G., Liu, J., Yan, Y., Zhao, S., Cai, F., Yu, X., Wang, Y., & Li, M. (2024) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2024.05.007 · Cited by 23
Associations between diabetes mellitus and sensorineural hearing loss from humans and animal studies
Williams, E. D., & Rubio, M. E. (2024) · Hearing Research · doi:10.1016/j.heares.2024.109072 · Cited by 25
Yang, Y., Wang, J., Lin, X., Zhang, Z., Zhang, M., Tang, C., Kou, X., & Deng, F. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150316 · Cited by 21
Unraveling the metabolic‒epigenetic nexus: a new frontier in cardiovascular disease treatment
Ouyang, J., Wu, D.-D., Gan, Y., Tang, Y., Wang, H., & Huang, J. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07525-z · Cited by 25
“For example, in the process of hyperglycemia, diabetes may still occur even if blood glucose levels return to normal [23, 24].”
Liu, Y., Li, K., Xu, J., Shen, W., Li, Y., Ma, J., Wang, T., Liu, J., Li, T., Zhang, X., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157214 · Cited by 26
Liang, C., Liu, X., Liu, C., Xu, Y., Geng, W., & Li, J. (2022) · Bioengineered · doi:10.1080/21655979.2022.2079254 · Cited by 22
“However, T2DM is a complex syndrome caused by islet dysfunction, and hyperglycemia is only one of its clinical features [31].”
BackgroundRetractedHelichrysum Genus and Compound Activities in the Management of Diabetes Mellitus
Akinfenwa, A. O., Sagbo, I. J., Makhaba, M., Mabusela, W. T., & Hussein, A. A. (2022) · Plants · doi:10.3390/plants11101386 · Cited by 22
Benrahou, K., Mrabti, H. N., Bouyahya, A., Daoudi, N. E., Bnouham, M., Mezzour, H., Mahmud, S., Alshahrani, M. M., Obaidullah, A. J., Cherrah, Y., et al. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/5868682 · Cited by 21
“+e etiology of type 2 diabetes is multiple, including genetic, epigenetic, environmental, and unhealthy lifestyle factors [1].”
BackgroundTraditional Medicine Use among Type 2 Diabetes Patients in KZN
Chetty, L., Govender, N., & Reddy, P. (2022) · Advances in Public Health · doi:10.1155/2022/7334080 · Cited by 23
“T1DM results from the destruction of pancreatic beta cells by T cells of the immune system [3, 7, 8], whereas T2DM is characterized by defective insulin secretion by pancreatic β-cells and the inability of insulin-sensitive tissues to react appropriately to insulin [9].”
BackgroundGrowing importance of urogenital candidiasis in individuals with diabetes: A narrative review
Talapko, J., Meštrović, T., & Škrlec, I. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i10.809 · Cited by 27
Kowalska, K., Wilczopolski, P., Buławska, D., Młynarska, E., Rysz, J., & Franczyk, B. (2022) · Antioxidants · doi:10.3390/antiox11122500 · Cited by 23
Wang, R., Yang, X., Jiang, Q., Chen, L., Gu, S., Shen, G., Liu, S., & Xiang, X. (2023) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12488 · Cited by 21
Nussrat, S. W., & Ad'hiah, A. H. (2023) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.409 · Cited by 29
Atta, I. S., Elnady, M. R., Alghamdi, A. G., Alghamdi, A. H., Aboulata, A. A., & Shatla, I. M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16031 · Cited by 24
“Type 2 Diabetes is one of the most prevalent metabolic diseases caused by decreased production of insulin by pancreatic beta cells, as well as a loss in the tissues’ ability to respond to insulin, resulting in hyperglycemia [1].”
BackgroundMendelian randomization indicates that atopic dermatitis contributes to the occurrence of diabetes
Lu, F., Wu, B., & Wang, Y. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01575-y · Cited by 24
“Type 2 diabetes (T2D) is defined as a chronic metabolic disease featured with insulin resistance and deficiency in insulin secretion [8], which is associated with additional metabolic disorders such as dyslipidemia and atherosclerosis [9].”
BackgroundKnapik, J. J., Farina, E. K., Steelman, R. A., Trone, D. W., & Lieberman, H. R. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.08.023 · Cited by 25
Keivanlou, M., Amini‐Salehi, E., Hassanipour, S., Zare, R., Mohammadi‐Vajari, E., Hashemi, M., Salari, A., & Porteghali, P. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998284844240102110559 · Cited by 22
A look at duodenal mucosal resurfacing: Rationale for targeting the duodenum in type 2 diabetes
Hoyt, J. A., Cozzi, E., D’Alessio, D. A., Thompson, C. C., & Aroda, V. R. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15533 · Cited by 21
Alshaikhi, S. A., Alamri, A. M., Alzilai, I. Y. A., Alghanimi, A. A., Alrufaidi, A. M. A., Alrufaidi, A. M., Bader, A. E., Abdelmoniem, A., Alshaikh, A. A., Alshaikhi, O. A., et al. (2024) · Future Science OA · doi:10.2144/fsoa-2023-0208 · Cited by 27
“Nonmodifiable risk factors include age, family history, ethnicity, and genetic factors [5–7] .”
BackgroundHill, T. G., & Hill, D. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074070 · Cited by 26
“…exacerbated by pre-existing obesity and/or aging, can progress from initial peripheral insulin resistance to beta-cell dysfunction and ultimately death, driven through the detrimental effects of gluco-and lipotoxicity, cellular stress, inflammatory processes, and islet amyloid deposition [148].”
BackgroundSahin, C., Melanson, J.-R., Billan, F. L., Magomedova, L., Ferreira, T. A. M., de Oliveira, A. S., Pollock‐Tahiri, E., Saikali, M. F., Cash, S. B., Woo, M., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101958 · Cited by 21
Cerasuolo, M., Auriemma, M. C., Meo, I. D., Lenti, C., Papa, M., Paolisso, G., & Rizzo, M. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146693 · Cited by 23
“In Type 2 diabetes (T2DM), insulin resistance in peripheral tissues, abnormalities in insulin signaling pathways, and hyperinsulinemia are key contributors to hyperglycemia [1].”
An integrated machine learning and fractional calculus approach to predicting diabetes risk in women
Amilo, D., Sadri, K., Hınçal, E., Farman, M. T., Nisar, K. S., & Hafez, M. M. (2025) · Healthcare Analytics · doi:10.1016/j.health.2025.100402 · Cited by 24
Potential of Quercetin as a Promising Therapeutic Agent Against Type 2 Diabetes
Niziński, P., Hawrył, A. M., Polak, P., Kondracka, A., Oniszczuk, T., Soja, J., Hawrył, M. A., & Oniszczuk, A. (2025) · Molecules · doi:10.3390/molecules30153096 · Cited by 25
“These processes are regulated by molecular mechanisms, any disruption of which can lead to an imbalance in the metabolic balance responsible for the development of the disease [2].”
Type 3 Diabetes: Linking Insulin Resistance to Cognitive Decline
Chapple, B. E., Bayliss, E., Woodfin, S., Smith, M., Winter, J., & Moore, W. (2025) · Diseases · doi:10.3390/diseases13110359 · Cited by 25
“Importantly, such receptor and IRS abnormalities have been observed in AD patients without type 2 diabetes, reinforcing the concept that central insulin resistance may arise independently and precede systemic metabolic dysfunction [73].”
Aloke, C., Adelusi, O. A., Onisuru, O. O., Iwuchukwu, E. A., & Achilonu, I. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70277 · Cited by 23
Mabate, B., Daub, C. D., Malgas, S., Edkins, A. L., & Pletschke, B. I. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111979 · Cited by 18
“T2DM is characterised by hyperglycemia, leading to considerable damage to organs, nervous and cardiovascular systems [3].”
BackgroundAttimarad, M., Venugopala, K. N., Chohan, M. S., David, M., Molina, E. I. P., Sreeharsha, N., Nair, A. B., Tratrat, C., Altaysan, A. I., & Balgoname, A. A. (2022) · Molecules · doi:10.3390/molecules27103135 · Cited by 20
“eventually leading to an increased blood glucose level [1,2].”
BackgroundDemırci, M., Taner, Z., Keskin, F. E., Özyazar, M., Kiraz, N., Kocazeybek, B., & Tokman, H. B. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01068-2 · Cited by 19
“While T1D is an autoimmune disease that develops as a result of an autoimmune response to pancreatic β cells, T2D is a disease associated with the defects of insulin secretion or insulin response [3, 4].”
BackgroundFilippello, A., Mauro, S. D., Scamporrino, A., Torrisi, S. A., Leggio, G. M., Pino, A. D., Scicali, R., Marco, M. D., Malaguarnera, R., Purrello, F., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147751 · Cited by 18
“The onset of obesity and associated type 2 diabetes mellitus (T2DM) is related to the increase in plasmatic free fatty acids (FFAs) [1].”
BackgroundIsmail, Y., Fahmy, D. M., Ghattas, M. H., Ahmed, M. M., Zehry, W., Saleh, S. M., & Abo–Elmatty, D. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.924478 · Cited by 22
“T2DM has two major pathophysiological arms: resistance to the action of insulin, primarily in the liver and other insulin-sensitive tissues; and pancreatic beta cell secretory dysfunction (Czech, 2017; Galicia-Garcia et al., 2020).”
BackgroundGurumayum, S., Bharadwaj, S., Sheikh, Y., Barge, S., Saikia, K., Swargiary, D., Ahmed, S. A., Thakur, D., & Borah, J. C. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115936 · Cited by 19
Adam, S. H., Nasri, N. M., Kashim, M. I. A. M., Latib, E. H. A., Juhari, M. A. A. A., & Mokhtar, M. H. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1057825 · Cited by 23
“Additionally, those with an increased percentage of body fat distributed in the abdominal region are also affected by T2DM (5, 6).”
BackgroundMulti-Omics Reveal Interplay between Circadian Dysfunction and Type2 Diabetes
Tiwari, A., Rathor, P., Trivedi, P. K., & Ch, R. (2023) · Biology · doi:10.3390/biology12020301 · Cited by 21
“The brain-centered glucoregulatory system can lower blood glucose levels via insulin-dependent mechanisms [25].”
BackgroundRegulation of glucolipid metabolism and gut microbiota by green and black teas in hyperglycemic mice
Zhou, H., Li, F., Wu, M., Zhu, J., Wang, Y., & Wei, X. (2023) · Food & Function · doi:10.1039/d3fo00355h · Cited by 20
Biosynthesis and Bioapplications of Nanomaterials from Mushroom Products
Nand, S., Mishra, D., Singh, P., Singh, M. P., Vamanu, E., & Petre, A. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230417083133 · Cited by 18
Lu, W., Chiu, C., Chan, Y., Mulio, A. T., & Li, P. (2023) · Nutrients · doi:10.3390/nu15132962 · Cited by 23
“T2DM is associated with hyperglycemia and is caused by defective insulin secretion by pancreatic β-cells and the inability of insulin-sensitive tissues to respond to insulin owing to a complex network of pathological conditions [37].”
BackgroundAttaye, I., Lassen, P. B., Adriouch, S., Steinbach, E., Patiño‐Navarrete, R., Davids, M., Alili, R., Jacques, F., Benzeguir, S., Belda, E., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107471 · Cited by 21
Fan, X., Wang, Y., Li, X., Zhong, T., Cheng, C., & Zhang, Y. (2023) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2023.03.007 · Cited by 18
Green synthesis of gold and silver nanoparticles as antidiabetic and anticancerous agents
Raza, M. A., Farwa, U., Mumtaz, M. W., Kainat, J., Sabir, A., & Al-Sehemi, A. G. (2023) · Green Chemistry Letters and Reviews · doi:10.1080/17518253.2023.2275666 · Cited by 18
“Diabetes ( 32 ), often known as diabetes mellitus or just diabetes, is a syndrome of excessively high blood sugar levels ( 32 ) brought by a malfunctioning metabolism and also due to inherited environmental factors (hyperglycemia) ( 33 ).”
BackgroundEndothelial progenitor cells as biomarkers of diabetes-related cardiovascular complications
Benítez-Camacho, J., Ballesteros, A., Beltrán-Camacho, L., Rojas-Torres, M., Rosal‐Vela, A., Jiménez-Palomares, M., Sánchez-Gomar, I., & Durán-Ruiz, M. C. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03537-8 · Cited by 23
Silk fibroin/chitosan pH-sensitive controlled microneedles
Jia, T., Kuang, D., Qi, Z., Tan, G., Yang, X., Kundu, S. C., & Lu, S. (2023) · Journal of Materials Science · doi:10.1007/s10853-023-09148-1 · Cited by 21
Alqahtani, Q. H., Alshehri, S., Alhusaini, A. M., Sarawi, W. S., Alqarni, S. S., Mohamed, R., Kumar, M. N., Alsaab, J. S., & Hasan, I. H. (2023) · Diseases · doi:10.3390/diseases11040184 · Cited by 22
“Long-term hyperglycemia progresses gradually and arises in both microvascular and macrovascular complications that affect multiple organs including the liver [4].”
BackgroundImmunomodulatory activities and biomedical applications of melittin and its recent advances
Jafari, Z., Sadeghi, S., Mirzarazi, M., Bigham, A., Honarmand, S., Tavasoli, A., Hoseini, M. H. M., & Varma, R. S. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202300569 · Cited by 21
Gallegos, L. I. F., Hernández, G. S. I. R., Mata, K. J. M., & Chávez, J. F. A. (2024) · Retos · doi:10.47197/retos.v53.101811 · Cited by 24
Halayal, R. Y., Bagewadi, Z. K., Aldabaan, N. A., Shaikh, I. A., & Khan, A. A. (2024) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2024.102026 · Cited by 23
Polyploidy and mTOR signaling: a possible molecular link
Choudhury, D., Ghosh, D., Mondal, M., Singha, D., Pothuraju, R., & Malakar, P. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01526-9 · Cited by 23
“2) [108].”
Adewuyi, E. O., Porter, T., O’Brien, E. K., Olaniru, O. E., Verdile, G., & Laws, S. M. (2024) · Communications Biology · doi:10.1038/s42003-024-06333-z · Cited by 18
Tu, Z., Du, J., Ge, X., Peng, W., Shen, L., Xia, L., Jiang, X., Hu, F., & Huang, S. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01609-3 · Cited by 20
“Chronic hyperglycemia and IR are known to contribute to vascular injury through various pathophysiological processes [15].”
BackgroundOganesova, Z., Pembérton, J. H., & Brown, A. C. (2024) · Diabetic Medicine · doi:10.1111/dme.15369 · Cited by 31
“4 For PNLD, given the relatively benign glucose fluctuations compared with T1DM and T2DM, point accuracy becomes the main criterion.”
InfluentialCholidis, P., Kranas, D., Chira, A., Galouni, E. A., Adamantidi, T., Anastasiadou, C., & Τσούπρας, Α. (2024) · Marine Drugs · doi:10.3390/md22120554 · Cited by 23
The Role of Dietary Anthocyanins for Managing Diabetes Mellitus-Associated Complications
Mistry, P. S., Chorawala, M. R., Sivamaruthi, B. S., Prajapati, B. G., Kumar, A., & Chaiyasut, C. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998322754240802063730 · Cited by 18
Kataria, S. K., Kadyan, P., Saini, J., Saharan, M., & Arasu, P. T. (2025) · International Journal of Biomaterials · doi:10.1155/ijbm/5841012 · Cited by 18
Ayoade, O. B., Shahrestani, S. A., & Ruan, C. (2025) · Electronics · doi:10.3390/electronics14132583 · Cited by 27
Wang, M., Yang, Q., Li, Y., Zhao, Y., Zou, J., Luan, F., Peng, X., Huang, Z., & Liu, F. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01222-x · Cited by 18
“Autophagic dysfunction in insulin-sensitive tissues (hypothalamus, skeletal muscle, liver, adipose) impairs their insulin sensitivity, gradually reducing pancreatic insulin secretion and worsening the disease [81].”
Jia, Y., Wang, R., Guo, D., Sun, L., Shi, M., Zhang, K., Yang, P., Zang, Y., Wang, Y., Liu, F., et al. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.04.019 · Cited by 20
Zhang, Y., Xu, G., Huang, B., Chen, D. S., & Ye, R. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01312-1 · Cited by 17
“Impaired insulin utilization is a key feature in T2DM, and emerging evidence showed that adipocytes are important regulators in controlling insulin resistance in T2DM [12, 13].”
BackgroundQin, Z., Xu, S., Yuan, R., Wang, Z., Lu, Y., Xu, Y., Lv, Y., Yu, F., Bai, J., Zhang, H., et al. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s376178 · Cited by 18
Interleukin-40 is a promising biomarker associated with type 2 diabetes mellitus risk
Nussrat, S. W., & Ad'hiah, A. H. (2023) · Immunology Letters · doi:10.1016/j.imlet.2023.01.006 · Cited by 19
Identification and analysis of type 2 diabetes-mellitus-associated autophagy-related genes
Cui, K., & Li, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1164112 · Cited by 20
“More than 90% of diabetes is T2DM, which is a chronic metabolic disease, manifested by high glucose levels induced by insulin resistance, defects in insulin secretion, or inadequate compensatory insulin secretory response (2, 3).”
BackgroundTan, J., Li, X., & Dou, N. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-023-07477-6 · Cited by 19
“The accumulation of hepatic glucose production in response to insulin resistance (IR) and impaired glucagon signaling inhibition is a major contributor to type 2 diabetes and its complications [1, 2].”
BackgroundHistorical View of Diabetics Mellitus: From Ancient Egyptian Polyuria to Discovery of Insulin
Mohajan, D., & Mohajan, H. K. (2023) · Studies in Social Science & Humanities · doi:10.56397/sssh.2023.07.05 · Cited by 19
Influence of type 2 diabetes and obesity on adipose mesenchymal stem/stromal cell immunoregulation
Mahmoud, M., & Rasheed, M. A. (2023) · Cell and Tissue Research · doi:10.1007/s00441-023-03801-6 · Cited by 21
“Hyperglycemia, oxidative stress, and inflammation in T2D contribute to vascular and nonvascular complications, causing socio-economic burdens (Vikram et al. 2014; Galicia-Garcia et al. 2020; Charlton et al. 2020).”
InfluentialAbu‐El‐Rub, E., Almahasneh, F. A., Khasawneh, R. R., Alzu’bi, A., Ghorab, D. S., Almazari, R., Magableh, H., Sanajleh, A., Shlool, H., Mazari, M., et al. (2023) · World Journal of Stem Cells · doi:10.4252/wjsc.v15.i12.1093 · Cited by 22
Multiple nanotechnological approaches using natural compounds for diabetes management
Stoleru, O. A., Burlec, A. F., Mircea, C., Felea, M. G., Macovei, I., Hăncianu, M., & Corciovă, A. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01376-1 · Cited by 27
Yang, X., Ding, W., Chen, Z., Lai, K., & Liu, Y. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3762 · Cited by 19
“78 83 In the following section, we provide a summary and illustration of the intricate association between autophagy and T2DM (Figure 3).”
Background1,3,4-Oxadiazole Scaffold in Antidiabetic Drug Discovery: An Overview
Gupta, O., Chawla, G., & Pradhan, T. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575298181240410041029 · Cited by 21
New insights into the roles of Irisin in diabetic cardiomyopathy and vascular diseases
Zhang, T., Qian, Y., Huang, W., Feng, J., & Liu, H. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116631 · Cited by 25
Mir, R., Alfaifi, J. A., Sohail, S. K., Rizvi, S. F., Akhtar, M. T., Alghamdi, M. A. A., Mir, R., Wani, J. I., Sabah, Z. U., Alhumaydhi, F. A., et al. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14070743 · Cited by 22
“Although the precise etiology has not yet been determined, there are a number of factors that have been proposed as possible contributors [14,15].”
BackgroundInfluentialXu, Y., Wang, Z., Li, S., Su, J., Gao, L., Ou, J., Lin, Z., Luo, O. J., Xiao, C., & Chen, G. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2695-x · Cited by 21
“Coope et al., 2016; Galicia-Garcia et al., 2020; Hotamisligil et al., 1993; Lau et al., 2019; Zeng et al., 2012 Tumors Breast cancer/prostate cancer/ lung cancer The T cells lose CD28, but show increased expression of KLRG1, CD57, PD-1 and CTLA-4, and secrete more immunosuppressive cytokines.”
The Role of Obesity as a Cardiac Disease Risk Factor in Patients with Type 2 Diabetes
Koirala, S., Sunnaa, M., Bernier, T. D., & Oktay, A. A. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02129-z · Cited by 17
“Some of the common pathways linking obesity and T2DM to CVD are chronic inflammation, insulin resistance, increased free fatty acid release, and adipokine deregulation [32, 33].”
El‐Huneidi, W., Anjum, S., Saleh, M. A., Bustanji, Y. K., Abu‐Gharbieh, E., & Taneera, J. (2022) · Molecules · doi:10.3390/molecules27072102 · Cited by 23
“Diabetes is a long-term metabolic disorder characterized by chronically high blood glucose levels [1].”
Background
Metadata
- Authors
- Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C.
- Affiliations
- Fundación Biofisika Bizkaia, Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Biofisika Institute (UPV/EHU, CSIC), Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Harvard University (US)
- CIC biomaGUNE (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-08-30
- Volume
- 21
- Issue
- 17
- Pages
- 6275
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7503727
- OpenAlex
- W3081655479
- Cited by
- 3,360
- References
- 297
- Citations by year
- 2026: 627 · 2025: 783 · 2024: 812 · 2023: 646 · 2022: 379 · 2021: 100 · 2020: 7
- FWCI
- 64.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Communities in ADDI (University of the Basque Country) (submittedVersion, other-oa)
- Communities in ADDI (Universidad del Pais Vasco) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Hispana (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- type 2 diabetes, insulin resistance, insulin secretion, pancreatic beta cells, insulin biosynthesis, insulin signaling, glucose homeostasis, gut dysbiosis, metabolic memory, nutrition, physical activity, atherosclerosis, cardiovascular risk
- MeSH terms
- Insulin Secretion, Animals, Blood Glucose, Diabetes Mellitus, Type 2, Homeostasis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.